U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837323) titled 'Flaxseed Oil, Olive Oil, and Their Combination on Hepatic and Metabolic Outcomes in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease' on Sept. 09.
Brief Summary: This 16-week randomized controlled trial evaluated the effects of flaxseed oil, extra virgin olive oil, and their combination on biochemical hepatic and metabolic outcomes in patients with MAFLD.
The study assessed CK-18 as the primary outcome, with BMI, HbA1c, liver enzymes, and lipid profile as secondary outcom
Study Start Date: June 25, 2024
Study Type: INTERVENTIONAL
Condition:
Liver Enzymes
Glucose Levels
Lipid Profile
Intervention:
DIETARY_SU...